EDGAR BUENO: Open Payments
NPI 1912692773 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$980 in 37 payments from 16 companies in 2025. Trend: 2023 $412 · 2024 $620 · 2025 $980
Food & beverage: $928Consulting: $52
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $244 |
| Alexion Pharmaceuticals, Inc. | 6 | $142 |
| Lundbeck LLC | 4 | $108 |
| Amgen Inc. | 3 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $75 |
| Chiesi USA, Inc. | 2 | $67 |
| ADMA BioManufacturing LLC | 2 | $52 |
| UCB, Inc. | 1 | $34 |
| Genentech USA, Inc. | 1 | $32 |
| GENZYME CORPORATION | 1 | $28 |
Products named: ULTOMIRIS, VYEPTI, ELFABRIO, UPLIZNA, TREMFYA, Rystiggo, Ocrevus Zunovo, ENTYVIO.
Industry payments across TX — which companies pay providers there.
